Imperial Ginseng Products Ltd.
IGPFF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.03 | 0.14 | -0.02 | 0.02 |
| FCF Yield | -208.67% | 10.63% | 79.71% | 61.55% |
| EV / EBITDA | -0.38 | -1.70 | -1.02 | -0.00 |
| Quality | ||||
| ROIC | -164.33% | -8.56% | -15.35% | -6.64% |
| Gross Margin | 0.00% | 1.17% | -5.98% | 2.49% |
| Cash Conversion Ratio | -6.34 | 0.35 | 2.53 | -0.57 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -15.77% | -15.89% | -2.70% |
| Free Cash Flow Growth | -230.33% | -82.64% | 128.29% | 253.96% |
| Safety | ||||
| Net Debt / EBITDA | 0.50 | -3.98 | -3.32 | 0.78 |
| Interest Coverage | -134.70 | -53.24 | -66.80 | -8.08 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | -42.34 | 1.81 | 2.23 |
| Cash Conversion Cycle | 0.00 | -17.19 | 141.85 | 137.22 |